Order Article Reprints

Gasanov VAo, Kashirskikh DA, Khotina VA, Kuzmina DM, Nikitochkina SY, Mukhina IV, Vorotelyak EA, Vasiliev AV. Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton’s Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33. Cells. 2025; 14(5):341. https://doi.org/10.3390/cells14050341

Gasanov, Vagif Ali oglu, Dmitry Alexandrovich Kashirskikh, Victoria Alexandrovna Khotina, Daria Mikhailovna Kuzmina, Sofya Yurievna Nikitochkina, Irina Vasilievna Mukhina, Ekaterina Andreevna Vorotelyak, and Andrey Valentinovich Vasiliev. 2025. "Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton’s Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33" Cells 14, no. 5: 341. https://doi.org/10.3390/cells14050341

Gasanov, V. A. o., Kashirskikh, D. A., Khotina, V. A., Kuzmina, D. M., Nikitochkina, S. Y., Mukhina, I. V., Vorotelyak, E. A., & Vasiliev, A. V. (2025). Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton’s Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33. Cells, 14(5), 341. https://doi.org/10.3390/cells14050341